{"result": "(\"entity\"<|>AMOR FERNÁNDEZ<|>PERSON<|>Amor Fernández is an author of the Manual de Endocrinología y Nutrición, which discusses treatment for dyslipidemias.)\n##\n(\"entity\"<|>VINAGRE TORRES<|>PERSON<|>Vinagre Torres is an author of the Manual de Endocrinología y Nutrición, contributing to the chapter on dyslipidemias.)\n##\n(\"entity\"<|>PEREA CASTILLA<|>PERSON<|>Perea Castilla is an author of the Manual de Endocrinología y Nutrición, focusing on the treatment of dyslipidemias.)\n##\n(\"entity\"<|>SOCIEDAD ESPAÑOLA DE ENDOCRINOLOGÍA Y NUTRICIÓN<|>ORGANIZATION<|>The Sociedad Española de Endocrinología y Nutrición is an organization that published the Manual de Endocrinología y Nutrición.)\n##\n(\"entity\"<|>HIPERCOLESTEROLEMIA FAMILIAR<|>EVENT<|>Hipercolesterolemia familiar is a genetic disorder characterized by high levels of LDL cholesterol, often leading to cardiovascular events.)\n##\n(\"entity\"<|>MADRID<|>GEO<|>Madrid is the capital of Spain and the location where the Manual de Endocrinología y Nutrición was published.)\n##\n(\"relationship\"<|>AMOR FERNÁNDEZ<|>SOCIEDAD ESPAÑOLA DE ENDOCRINOLOGÍA Y NUTRICIÓN<|>Amor Fernández is an author associated with the Sociedad Española de Endocrinología y Nutrición, contributing to their publications<|>7)\n##\n(\"relationship\"<|>VINAGRE TORRES<|>SOCIEDAD ESPAÑOLA DE ENDOCRINOLOGÍA Y NUTRICIÓN<|>Vinagre Torres is an author associated with the Sociedad Española de Endocrinología y Nutrición, contributing to their publications<|>7)\n##\n(\"relationship\"<|>PEREA CASTILLA<|>SOCIEDAD ESPAÑOLA DE ENDOCRINOLOGÍA Y NUTRICIÓN<|>Perea Castilla is an author associated with the Sociedad Española de Endocrinología y Nutrición, contributing to their publications<|>7)\n##\n(\"relationship\"<|>HIPERCOLESTEROLEMIA FAMILIAR<|>AMOR FERNÁNDEZ<|>Amor Fernández discusses Hipercolesterolemia familiar in the Manual de Endocrinología y Nutrición<|>8)\n##\n(\"relationship\"<|>HIPERCOLESTEROLEMIA FAMILIAR<|>VINAGRE TORRES<|>Vinagre Torres discusses Hipercolesterolemia familiar in the Manual de Endocrinología y Nutrición<|>8)\n##\n(\"relationship\"<|>HIPERCOLESTEROLEMIA FAMILIAR<|>PEREA CASTILLA<|>Perea Castilla discusses Hipercolesterolemia familiar in the Manual de Endocrinología y Nutrición<|>8)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: > 180/110 mmHg); 2) diabetes mellitus sin otro factor de riesgo cardiovascular o lesión de órgano diana (excepto los pacientes jóvenes con diabetes tipo 1 sin factores de riesgo, que se podrían clasificar de riesgo bajo o moderado); 3) insuficiencia renal crónica moderada (filtrado glomerular estimado entre 30 y 59 ml/min/1,73 m2), y 4) un riesgo estimado mediante SCORE ≥ 5%, pero <10%.\n\nEl objetivo terapéutico, en este grupo, es un colesterol LDL < 100 mg/dl o una reducción de al menos un 50% si el colesterol LDL está comprendido entre 100 y 200 mg/dl.\n\n#### Riesgo moderado\n\nEste grupo incluye a aquellos sujetos con un riesgo SCORE ≥ 1%, pero <5%, y sin ninguna de las condiciones de los supuestos de riesgo alto o muy alto.\n\nEl objetivo terapéutico, en este grupo, es un colesterol LDL < 115 mg/dl.\n\n#### Riesgo bajo\n\nEste grupo incluye a aquellos sujetos con un riesgo SCORE < 1% y sin ninguna de las condiciones de los supuestos de riesgo alto o muy alto.\n\nEl objetivo terapéutico, en este grupo, es similar al de riesgo moderado: colesterol LDL < 115 mg/dl.\n\nReferencias:\n- Amor Fernández AJ, Vinagre Torres I, Perea Castilla V. Manual de Endocrinología y Nutrición [Internet]. Madrid: Sociedad Española de Endocrinología y Nutrición; 2018. Capítulo 125. Tratamiento de las dislipemias. [citado 11 de noviembre de 2019]. Disponible en: https://manual.seen.es/article?id=5559fe85-9644-42fd-966a-6a43ac18103c\n---\n# OBESIDAD, LÍPIDOS Y TRASTORNOS ELECTROLÍTICOS\n\n## 30. Hombre de 34 años, remitido a la consulta por presentar cifras de colesterol LDL superiores a 250 mg/dl, de forma persistente. En la exploración se aprecia la presencia de manchas induradas blanquecinas en codos, rodillas y párpados. Su TA es de 135/85 mmHg. Su padre murió de infarto de miocardio a la edad de 48 años. En la analítica, realizada en ayunas, destaca un colesterol total de 346 mg/dl, un colesterol LDL de 278 mg/dl, un colesterol HDL de 42 mg/dl, unos triglicéridos de 130 mg/dl y una glucosa de 93 mg/dl. Respecto a la enfermedad que padece este paciente, una de las siguientes afirmaciones es falsa. Señale cuál:\n\nA. Se trata de una enfermedad hereditaria autosómica dominante, con una alta penetrancia, por lo que es frecuente que alguno de los progenitores y hermanos del individuo la padezcan también.\nB. El trastorno genético afecta al gen que codifica el receptor del colesterol LDL y se han descrito más de 900 mutaciones.\nC. Los varones no tratados tienen una probabilidad cercana al 50% de sufrir un evento coronario antes de los 60 años, y las mujeres con la enfermedad presentan una prevalencia de cardiopatía isquémica superior a la de la población general femenina.\nD. El trastorno genético afecta también a la síntesis de los triglicéridos, provocando, en las fases avanzadas de la enfermedad, un incremento de estos, que suele ser superior a los 500 mg/dl.\n\n### COMENTARIO\n\nLa hipercolesterolemia familiar es un trastorno genético codominante que en forma heterocigota se da aproximadamente en uno de cada 500 individuos. Actualmente, se conocen más de 1.600 mutaciones diferentes a lo largo de todo el gen del receptor de las LDL en individuos con hipercolesterolemia familiar procedentes de diversas poblaciones a nivel mundial. Los niveles de colesterol LDL están elevados al nacer y permanecen así durante toda la vida. En adultos no tratados, los niveles oscilan entre 275 y 500 mg/dl, mientras que los niveles de triglicéridos y HDL permanecen normales e incluso bajos en estos últimos. Se observan xantomas tendinosos que son depósitos intra- y extracelulares de colesterol en los tendones. La forma homocigota de hipercolesterolemia familiar tiene una frecuencia de un individuo por millón y se acompaña de niveles de colesterol plasmático superiores a 500 mg/dl.\n\nReferencias:\n- Cardona F, Alcaide J, Fernández García JC. Manual de Endocrinología y Nutrición [Internet]. Madrid: Sociedad Española de Endocrinología y Nutrición; 2015. Capítulo 124. Epidemiología, diagnóstico y clasificación de las dislipemias; [citado 11 de noviembre de 2019]. Disponible en: https://manual.seen.es/article?id=551150\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}